AzTrials
AzTrials

Preterm BirthNCT07402668

Does AI Make Clinicians More Appropriately Confident? A Randomized Study in Preterm Birth Prediction

A study testing AI prediction (binary) and AI risk estimate (%) in people with Preterm Birth and Artificial Intelligence (AI) in Diagnosis, run by Copenhagen University Hospital, Rigshospitalet at 18 sites in Denmark.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this randomized questionnaire-based study is to evaluate how different presentations of artificial intelligence (AI) decision support influence clinical judgment among medical doctors working in obstetrics and gynecology when assessing the risk of spontaneous preterm birth using clinical case vignettes… Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
What is being tested?
AI prediction (binary) and AI risk estimate (%)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
125 participants
Where
18 sitesDenmark
Study dates
3 Feb 2026to Jul 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Medical doctors currently working in or training within the field of obstetrics and gynecology.
  • Experience performing transvaginal cervical ultrasound examinations.

Who cannot join

  • No prior experience performing transvaginal cervical ultrasound examinations.

Trial locations and contacts

18 sites in 1 country. Contact the study team or a site near you to ask about taking part.

18 sites in 1 country

Denmark18 sites, 18 recruiting
  • South Jutland Hospital

    Aabenraa, 6200

    Emilie Pi F Sejer, 0045 28890690, emilie.pi.fogtmann.sejer.01@regionh.dk

    Recruiting
  • Aalborg University Hospital (Aalborg and Thisted)

    Aalborg, 9000

    Emilie Pi F Sejer, MD, 0045 28890690, emilie.pi.fogtmann.sejer.01@regionh.dk

    Recruiting
  • Aarhus University Hospital

    Aarhus, 8200

    Emilie Pi F Sejer, MD, 0045 28890690, emilie.pi.fogtmann.sejer.01@regionh.dk

    Recruiting
  • Copenhagen University Hospital, Rigshospitalet

    Copenhagen, 2100

    Emilie Pi F Sejer, MD, 0045 28890690, emilie.pi.fogtmann.sejer.01@regionh.dk

    Recruiting
  • Esbjerg Hospital

    Esbjerg, 6700

    Emilie Pi F Sejer, MD, 0045 28890690, emilie.pi.fogtmann.sejer.01@regionh.dk

    Recruiting
  • Gødstrup Regional Hospital

    Gødstrup, 7400

    Emilie Pi F Sejer, MD, 0045 28890690, emilie.pi.fogtmann.sejer.01@regionh.dk

    Recruiting
  • Herlev Hospital

    Herlev, 2730

    Emilie Pi F Sejer, MD, 0045 28890690, emilie.pi.fogtmann.sejer.01@regionh.dk

    Recruiting
  • Copenhagen University Hospital, North Zealand

    Hillerød, 3400

    Emilie Pi F Sejer, MD, 0045 28890690, emilie.pi.fogtmann.sejer.01@regionh.dk

    Recruiting
  • Region Hospital North Jutland

    Hjørring, 9800

    Emilie Pi F Sejer, MD, 0045 28890690, emilie.pi.fogtmann.sejer.01@regionh.dk

    Recruiting
  • Holbæk Hospital

    Holbæk, 4300

    Emilie Pi F Sejer, MD, 0045 28890690, emilie.pi.fogtmann.sejer.01@regionh.dk

    Recruiting
  • Horsens Regional Hospital

    Horsens, 8700

    Emilie Pi F Sejer, MD, 0045 28890690, emilie.pi.fogtmann.sejer.01@regionh.dk

    Recruiting
  • Hvidovre Hospital

    Hvidovre, 2650

    Emilie Pi F Sejer, MD, 0045 28890690, emilie.pi.fogtmann.sejer.01@regionh.dk

    Recruiting
  • Kolding Hospital

    Kolding, 6000

    Emilie Pi F Sejer, MD, 0045 28890690, emilie.pi.fogtmann.sejer.01@regionh.dk

    Recruiting
  • Odense University Hospital (Odense and Svendborg)

    Odense, 5000

    Emilie Pi F Sejer, MD, 0045 28890690, emilie.pi.fogtmann.sejer.01@regionh.dk

    Recruiting
  • Randers Regional Hospital

    Randers, 8930

    Emilie Pi F Sejer, MD, 0045 28890690, emilie.pi.fogtmann.sejer.01@regionh.dk

    Recruiting
  • Zealand University Hospital (Roskilde and Nykøbing F.)

    Roskilde, 4000

    Emilie Pi F Sejer, MD, 0045 28890690, emilie.pi.fogtmann.sejer.01@regionh.dk

    Recruiting
  • Slagelse Hospital

    Slagelse, 4200

    Emilie Pi F Sejer, MD, 0045 28890690, emilie.pi.fogtmann.sejer.01@regionh.dk

    Recruiting
  • Viborg Regional Hospital

    Viborg, 8800

    Emilie Pi F Sejer, MD, 0045 28890690, emilie.pi.fogtmann.sejer.01@regionh.dk

    Recruiting

Other trials in Denmark

About this study

The goal of this randomized questionnaire-based study is to evaluate how different presentations of artificial intelligence (AI) decision support influence clinical judgment among medical doctors working in obstetrics and gynecology when assessing the risk of spontaneous preterm birth using clinical case vignettes with cervical ultrasound images. The study specifically compares two AI presentation formats: a binary classification (preterm vs term birth) and an individualized risk estimate of preterm birth.

The main questions it aims to answer are:

Read more
  • Which AI presentation format leads to better alignment between clinicians' confidence and decision accuracy (diagnostic calibration)?
  • Do different AI presentation formats lead to helpful or harmful changes in clinical decisions?

Participants will complete an online questionnaire in which they review clinical cases, make diagnostic and management decisions, rate their diagnostic confidence before and after seeing the AI output, and report their trust in the AI.

Being tested
AI prediction (binary), AI risk estimate (%)
Keywords
Preterm birth, Premature birth, Diagnostic calibration, Diagnostic accuracy, Diagnostic confidence, Artificial intelligence
Medical subject headings
Premature Birth

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • AI prediction (binary)Behavioural

    AI decision support based on cervical ultrasound providing a binary classification (preterm birth before 37 weeks or term birth) in addition to standard clinical information.

  • AI risk estimate (%)Behavioural

    AI decision support based on cervical ultrasound providing an estimate of preterm birth risk (%) in addition to standard clinical information.

Study groups in NCT07402668
Study groupRoleWhat they receive
AI predictionExperimentalThe participants receive a binary AI prediction (preterm or term birth)
Receives: Behavioral: AI prediction (binary)
AI risk estimateExperimentalThe participants receive an AI risk estimate of preterm birth (%)
Receives: Behavioral: AI risk estimate (%)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Clinician diagnostic calibration (accuracy-confidence alignment) after AI exposure.

    Agreement between post-AI decision correctness (0/1) and post-AI confidence rating (0-10) will be quantified using the Brier score. Confidence will be rescaled to 0-1 and squared differences between confidence and correctness will be averaged across cases to produce a participant-level score. Lower scores indicate better diagnostic calibration. Results will be compared between randomized arms.

    Measured: Immediately after AI exposure during a single questionnaire session (approximately 20 minutes).

Secondary outcomes (4)
  1. Helpful switch rate and harmful switch rate.

    Proportion of cases with helpful and harmful switches calculated for each participant and compared between study arms.

    Helpful switch = incorrect pre-AI decision changing to correct post-AI decision.

    Harmful switch = correct pre-AI decision changing to incorrect post-AI decision.

    Measured: Baseline (pre-AI) and immediately after AI exposure during a single questionnaire session (approximately 20 minutes).

  2. Change in decision accuracy, confidence, and diagnostic calibration from pre-AI to post-AI.

    Within-participant change from pre-AI to post-AI in decision accuracy (proportion of correct decisions), confidence rating, and diagnostic calibration. Differences will be compared between randomized arms and stratified by AI correctness.

    Measured: Baseline (pre-AI) and immediately after AI exposure during a single questionnaire session (approximately 20 minutes).

  3. Association between self-rated trust in AI and behavioral reliance on AI.

    Self-rated trust in the AI output will be measured using a numeric rating scale (0-10) after AI exposure for each case. Behavioral reliance will be quantified as the proportion of post-AI decisions concordant with the AI output. The relationship between trust ratings and behavioral reliance, including concordance when the AI is correct and incorrect, will be evaluated at the participant level and compared between randomized arms.

    Measured: Immediately after AI exposure during a single questionnaire session (approximately 20 minutes).

  4. Follow-up cervical ultrasound planning.

    Proportion of cases in which clinicians plan an additional cervical ultrasound (yes/no), summarized per participant and compared pre-post AI and between randomized arms.

    Measured: Baseline (pre-AI) and immediately after AI exposure during a single questionnaire session (approximately 20 minutes).

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Feb 2026
  2. Study start3 Feb 2026
  3. Primary completionJul 2026 (estimated)
  4. Study completionJul 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
125 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07402668
Sponsor's protocol ID
P-2024-18108
Status last verified
Jun 2026
First submitted
27 Jan 2026
Last updated
1 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data are not planned to be publicly shared. Aggregate results will be reported. De-identified data may be made available upon reasonable request and subject to institutional policies and applicable data protection regulations.

Questions about this trial

What is this clinical trial studying?

A study testing AI prediction (binary) and AI risk estimate (%) in people with Preterm Birth and Artificial Intelligence (AI) in Diagnosis, run by Copenhagen University Hospital, Rigshospitalet at 18 sites in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 1 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 18 sites in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Emilie Pi F Sejer, MD (0045 28890690, emilie.pi.fogtmann.sejer.01@regionh.dk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Clinician diagnostic calibration (accuracy-confidence alignment) after AI exposure. (time frame: Immediately after AI exposure during a single questionnaire session (approximately 20 minutes).). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Jul 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT07402668 | AzTrials